Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

560 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Three-month dual antiplatelet therapy after implantation of zotarolimus-eluting stents: the DATE (Duration of Dual Antiplatelet Therapy AfterImplantation of Endeavor Stent) registry.
Hahn JY, Song YB, Choi JH, Choi SH, Lee SY, Park HS, Hur SH, Lee S, Han KR, Rha SW, Cho BR, Park JS, Yoon J, Lim DS, Lee SH, Gwon HC; DATE Registry Investigators. Hahn JY, et al. Among authors: rha sw. Circ J. 2010 Nov;74(11):2314-21. doi: 10.1253/circj.cj-10-0347. Epub 2010 Oct 2. Circ J. 2010. PMID: 20938098 Free article.
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.
Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, Kim SW, Bui A, Gevorkian N, Xue Z, Smith K, Fournadjieva J, Suddath WO, Satler LF, Pichard AD, Kent KM, Waksman R. Kuchulakanti PK, et al. Among authors: rha sw. Circulation. 2006 Feb 28;113(8):1108-13. doi: 10.1161/CIRCULATIONAHA.105.600155. Epub 2006 Feb 20. Circulation. 2006. PMID: 16490815
Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents.
Kuchulakanti PK, Torguson R, Chu WW, Canos DA, Rha SW, Clavijo L, Deible R, Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R. Kuchulakanti PK, et al. Among authors: rha sw. Am J Cardiol. 2006 Mar 15;97(6):792-7. doi: 10.1016/j.amjcard.2005.10.018. Epub 2006 Jan 18. Am J Cardiol. 2006. PMID: 16516578
N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
Kwon TG, Bae JH, Jeong MH, Kim YJ, Hur SH, Seong IW, Cho MC, Seung KB, Jang YS, Park SJ; Korea Acute Myocardial Infarction Registry Investigators. Kwon TG, et al. Int J Cardiol. 2009 Apr 3;133(2):173-8. doi: 10.1016/j.ijcard.2007.12.022. Epub 2008 Feb 20. Int J Cardiol. 2009. PMID: 18281115
Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Chen KY, Rha SW, Li YJ, Poddar KL, Jin Z, Minami Y, Wang L, Kim EJ, Park CG, Seo HS, Oh DJ, Jeong MH, Ahn YK, Hong TJ, Kim YJ, Hur SH, Seong IW, Chae JK, Cho MC, Bae JH, Choi DH, Jang YS, Chae IH, Kim CJ, Yoon JH, Chung WS, Seung KB, Park SJ; Korea Acute Myocardial Infarction Registry Investigators. Chen KY, et al. Among authors: rha sw. Circulation. 2009 Jun 30;119(25):3207-14. doi: 10.1161/CIRCULATIONAHA.108.822791. Epub 2009 Jun 15. Circulation. 2009. PMID: 19528339 Free article.
Lack of clinical benefit of improved angiographic results with sirolimus-eluting stents compared with paclitaxel and zotarolimus-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Choi CU, Rha SW, Chen KY, Li YJ, Poddar KL, Jin Z, Minami Y, Suh SY, Na JO, Lim HE, Kim JW, Kim EJ, Park CG, Seo HS, Oh DJ. Choi CU, et al. Among authors: rha sw. Circ J. 2009 Dec;73(12):2229-35. doi: 10.1253/circj.cj-08-1086. Epub 2009 Sep 29. Circ J. 2009. PMID: 19789418 Free article.
560 results